Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation


    Yu Zhao — scientific strength (skeptical assessment): Based on the provided evidence, Yu Zhao shows high technical breadth across computational biology/ML, imaging, immunology, and molecular mechanism work, including quantitative pipelines and mechanistic experiments. However, the supplied author metadata appears identity-confounded (multiple “Zhao/Yu Zhao” records and non-matching disciplinary outputs), which substantially limits confidence in a “single-author” track-record evaluation.
    Anchor evidence examples (from the provided source list): cytokine meta-analysis, phosphorylation switch, phylogenomics + ML morphology, fork-MMEJ repair mechanism.



     Long Explanation


    Author Review: Yu Zhao
    Date context: April 11, 2026 • Mode: evidence-weighted, skeptical, science-focused • Bias controls: identity-confounding risk acknowledged
    What we can and cannot conclude from the provided data
    • Known (from provided evidence): multiple works include computational modeling/pipelines, quantitative statistics, and mechanistic experiments across disparate biological topics.
    • Uncertain / potentially disconfirmed: the supplied “Yu Zhao” author identity appears not consistently anchored—e.g., some OpenAlex-like entries in the prompt map to other names, and the separately listed “Yu Zhao” publications include non-overlapping subject areas. This can’t be resolved without a definitive ORCID/affiliation/paper list for the same individual.
    • Implication: all “track record” confidence is capped by potential name ambiguity (a classic bibliometric failure mode).
    Evidence map (provided DOIs/papers): by study type
    Selected quantitative signals from provided raw excerpts (not exhaustive)
    This figure plots only the explicit numeric values present in the prompt’s extracted “list_of_extracted_data” blocks.
    1) Scientific content & biological plausibility (evidence-weighted)
    Mechanistic depth (examples)
    • Cell-fate phospho-switch: the provided extracted evidence describes phosphorylation at SALL4 T903 gating chromatin remodeling via differential association with BAF vs NuRD, connected to BMP4–DUSP9 signaling and with targeted alanine substitutions plus multi-omics (RNA-seq/ATAC-seq) and in vivo mouse phenotypes. Reported specificity is emphasized by failure of phosphomimetics (T903D/E) to fully rescue, supporting a “site-specific certification” notion rather than charge-only effects. Cited paper evidence: includes T903A loss (~90%) and chromatin accessibility/interaction claims with stated modeling (including AlphaFold3 docking/modeling) and specified in vivo lethality.
    • Replication fork repair pathway choice: the provided evidence claims a direct fork-associated MMEJ route (fork-MMEJ) at broken replication forks, regulated by ATR with Polθ dependence and acting in tandem with BIR; it further states targeted deep sequencing and DNA fiber readouts. Cited paper evidence.
    Quantitative data integration & reproducibility signals (examples)
    • Non-model QC / pipeline engineering: resolveS is presented as reference-free strandedness detection using universal rRNA and “progressive MAPQ-filtered voting,” with explicit concordance (249/252; 98.81%) and reported runtime/memory constraints. Cited paper evidence.
    • Mechanistic + omics biomarker inference: TNFRSF4 as a favorable prognostic immune-associated biomarker for endometrial carcinoma is supported in the extracted evidence by TCGA + GEO meta-analysis and tissue microarray validations, including reported effect sizes (e.g., SMD 0.34) and survival association (HR 0.317) along with immune infiltration correlations. Cited paper evidence.
    • Reference-population data integration: Pantheon 1.0 is described as a manually verified multilingual dataset of biographies with popularity proxies and explicit bias/limitation discussion; it includes dataset scale (11,341 biographies) and methods linking pageviews/popularity metrics to historical accomplishment proxies. Cited paper evidence.
    2) Skeptical critique: major limitations & blind spots
    • Author identity confounding limits any “single-person expertise” inference. The prompt includes bibliometrics-like numbers (h-index/citations) and also an OpenAlex-like block that does not clearly correspond to the same person named “Yu Zhao.” Without a unique identifier (e.g., ORCID) that ties all provided papers to one individual, it’s scientifically unsafe to claim a unified career trajectory.
    • Cross-domain breadth may reflect collaboration/role diversity or may reflect name ambiguity. The evidence set spans transcription-factor cell fate, vascular smooth muscle disease, bacterial secretion systems, phylogenomics with image ML, and imaging hardware—each plausible for a computational/biomedical scientist, but the prompt’s identity issue makes it unclear whether this is truly one researcher’s portfolio.
    • Mechanistic claims still face standard generalizability constraints. Example: phospho-switch work is mouse-centric with claims relying partly on docking/modeling and no single-cell lineage tracing according to the extracted limitations; thus “causal mechanism across species/cell types” remains uncertain even if internal evidence is strong. Limitation context cited
    • Biomarker studies: correlation ≠ causation. TNFRSF4 evidence includes computational deconvolution (CIBERSORT/ESTIMATE-style) and IHC validation; however the excerpted limitations explicitly note lack of functional causality. Cited limitations.
    • Meta-analyses: observational confounding and heterogeneity remain. The ALS cytokine meta-analysis reports effect sizes for several cytokines but also highlights heterogeneity and the cross-sectional nature, limiting causal claims. Cited meta-analysis.
    3) What information would disprove / change this assessment?
    • If an ORCID/affiliation link shows that the provided papers are not attributable to the same “Yu Zhao,” then the perceived scientific breadth and rigor can’t be credited to a single author.
    • If independent audits (e.g., reanalysis with raw-data access) fail to reproduce key quantitative results in the cited pipeline/mechanistic papers, rigor would drop.
    • If the mechanistic directionality (e.g., “T903 certification” vs alternative regulatory pathways) fails under additional cell types or stronger structural validation (e.g., direct structural determination rather than docking), mechanistic certainty would decrease.
    Key evidence used (inline-cited)


    Feedback:    

    Updated: April 11, 2026

     Top Data Sources ExportMCP


     Analysis Wizard



    Not provided: the query is an author review, not a bioinformatics task tied to uploaded raw datasets.



     Hypothesis Graveyard


    The “phosphomimetics fail because the site can never be functionally substituted” hypothesis is weaker if additional compensatory mutations (outside local charge) restore chromatin accessibility and reprogramming—then the primary limitation wouldn’t be site-specific certification alone.


    A strongman claim that “peripheral cytokine elevations in ALS are specific biomarkers causally driving disease progression” is undermined if effects remain non-causal, highly confounded by age/controls, or fail prospective longitudinal validation.

     Science Art


    Author Review: Yu Zhao Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT






     Trending